Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation - PubMed (original) (raw)
. 2009 Nov;276(21):6324-37.
doi: 10.1111/j.1742-4658.2009.07346.x. Epub 2009 Oct 1.
Affiliations
- PMID: 19796173
- DOI: 10.1111/j.1742-4658.2009.07346.x
Free article
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
Nora Göckler et al. FEBS J. 2009 Nov.
Free article
Abstract
DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues. Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase. Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells. Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively). Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm). Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells. Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome. Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons. In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.
Similar articles
- DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine.
Seifert A, Allan LA, Clarke PR. Seifert A, et al. FEBS J. 2008 Dec;275(24):6268-80. doi: 10.1111/j.1742-4658.2008.06751.x. Epub 2008 Nov 7. FEBS J. 2008. PMID: 19016842 - Mechanism of dual specificity kinase activity of DYRK1A.
Walte A, Rüben K, Birner-Gruenberger R, Preisinger C, Bamberg-Lemper S, Hilz N, Bracher F, Becker W. Walte A, et al. FEBS J. 2013 Sep;280(18):4495-511. doi: 10.1111/febs.12411. Epub 2013 Jul 22. FEBS J. 2013. PMID: 23809146 - The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
Egusa H, Doi M, Saeki M, Fukuyasu S, Akashi Y, Yokota Y, Yatani H, Kamisaki Y. Egusa H, et al. Bone. 2011 Aug;49(2):264-74. doi: 10.1016/j.bone.2011.04.003. Epub 2011 Apr 12. Bone. 2011. PMID: 21504804 - Activation, regulation, and inhibition of DYRK1A.
Becker W, Sippl W. Becker W, et al. FEBS J. 2011 Jan;278(2):246-56. doi: 10.1111/j.1742-4658.2010.07956.x. Epub 2010 Dec 3. FEBS J. 2011. PMID: 21126318 Review. - MNB/DYRK1A as a multiple regulator of neuronal development.
Tejedor FJ, Hämmerle B. Tejedor FJ, et al. FEBS J. 2011 Jan;278(2):223-35. doi: 10.1111/j.1742-4658.2010.07954.x. Epub 2010 Dec 13. FEBS J. 2011. PMID: 21156027 Review.
Cited by
- 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A.
Falke H, Chaikuad A, Becker A, Loaëc N, Lozach O, Abu Jhaisha S, Becker W, Jones PG, Preu L, Baumann K, Knapp S, Meijer L, Kunick C. Falke H, et al. J Med Chem. 2015 Apr 9;58(7):3131-43. doi: 10.1021/jm501994d. Epub 2015 Mar 23. J Med Chem. 2015. PMID: 25730262 Free PMC article. - A review on medicinal importance, pharmacological activity and bioanalytical aspects of beta-carboline alkaloid ''Harmine''.
Patel K, Gadewar M, Tripathi R, Prasad SK, Patel DK. Patel K, et al. Asian Pac J Trop Biomed. 2012 Aug;2(8):660-4. doi: 10.1016/S2221-1691(12)60116-6. Asian Pac J Trop Biomed. 2012. PMID: 23569990 Free PMC article. Review. - DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions.
Zhang C, Wu LW, Li ZD, Zhang MM, Wu J, Du FH, Zeng LH, Li YL. Zhang C, et al. Int J Oncol. 2022 Apr;60(4):45. doi: 10.3892/ijo.2022.5335. Epub 2022 Mar 4. Int J Oncol. 2022. PMID: 35244188 Free PMC article. - Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome.
Stensen W, Rothweiler U, Engh RA, Stasko MR, Bederman I, Costa ACS, Fugelli A, Svendsen JSM. Stensen W, et al. Pharmaceuticals (Basel). 2021 Nov 17;14(11):1170. doi: 10.3390/ph14111170. Pharmaceuticals (Basel). 2021. PMID: 34832952 Free PMC article. - The neurodevelopmental disorder risk gene DYRK1A is required for ciliogenesis and control of brain size in Xenopus embryos.
Willsey HR, Xu Y, Everitt A, Dea J, Exner CRT, Willsey AJ, State MW, Harland RM. Willsey HR, et al. Development. 2020 Jun 22;147(21):dev189290. doi: 10.1242/dev.189290. Development. 2020. PMID: 32467234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases